# Miraca Holdings

> Miraca Holdings is a VC fund in Tokyo backing Medical, Biotechnology and Consulting. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Tokyo, Japan
- Total investments: 7
- Last investment: Jun 2020
- Lead investor: 14%
- Last updated: Aug 2026
- LinkedIn: https://in.linkedin.com/company/miraca
- Website: https://www.miraca.com

Miraca Holdings is a VC fund in Tokyo focused on Medical and Biotechnology. Miraca Holdings Inc. is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and healthcare related business

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 4 | 57% |
| Biotechnology | 3 | 43% |
| Consulting | 2 | 29% |
| Health Care | 2 | 29% |
| Medical Device | 2 | 29% |

14 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 3 | 43% |
| Venture - Series Unknown | 2 | 29% |
| Series A | 1 | 14% |
| Series C | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Catalyna | Catalyna is a Japan-based company that provides its users with system development and handing solutions. It was founded in 2015 and is headquartered in Tokyo, Japan. |  | Venture - Series Unknown | Jun 25, 2020 |  |
| Kringle Pharma | Kringle Pharma, Inc., a biopharmaceutical company, develops pharmaceutical products based on its research on hepatocyte growth factor (HGF) and NK4. Its HGF has the regenerative healing ability in regard to liver cells, as well as various cells and organs; and NK4 is a bi-functional molecule, which inhibits the invasion and metastasis of tumorcells as an HGF-antagonist, as well as possesses antiangiogenic activity. The company’s pipeline includes recombinant human HGF for the treatment of acute renal failure, skin ulcers, and CNS diseases; and recombinant human NK4 and NK4 gene drugs for cancer therapy. Kringle Pharma, Inc. was founded in 2001 and is based in Toyonaka, Japan. | $104.9M |  | Apr 04, 2020 |  |
| Kringle Pharma | Kringle Pharma, Inc., a biopharmaceutical company, develops pharmaceutical products based on its research on hepatocyte growth factor (HGF) and NK4. Its HGF has the regenerative healing ability in regard to liver cells, as well as various cells and organs; and NK4 is a bi-functional molecule, which inhibits the invasion and metastasis of tumorcells as an HGF-antagonist, as well as possesses antiangiogenic activity. The company’s pipeline includes recombinant human HGF for the treatment of acute renal failure, skin ulcers, and CNS diseases; and recombinant human NK4 and NK4 gene drugs for cancer therapy. Kringle Pharma, Inc. was founded in 2001 and is based in Toyonaka, Japan. | $6.8M | Series C | Mar 02, 2020 |  |
| AGREE | AGREE is an application developer and operator for medical consultation. Its product is the medical consultation application, LEBER. It allows its users to consult with a doctor on their smartphone 24/7. It was founded in 2017 and is headquartered in Tsukuba, Ibaraki Prefecture, Japan. | $3.9M | Venture - Series Unknown | Feb 05, 2020 |  |
| SmartScan | SmartScan is a Japanese company that manufactures preventive medicines. SmartScan's mission is to create and provide an image screening environment that is easy for anyone to visit. | $7.3M | Series A | Nov 28, 2019 |  |
| Junten Bio | JUNTEN BIO is a company is to develop new technologies in the field of regenerative medicine. | $1.8M |  | Dec 17, 2018 |  |
| HIROTSU BIO SCIENCE | HIROTSU BIO SCIENCE is a biotechnology company. | $198.4M |  | Aug 06, 2018 |  |

7 of 7 investments shown.

## Co-investors
- [H.U. Group Central Research Institute](https://shizune.co/investors/profile/h-u-group-holdings) — VC Fund, 4 deals together
- [Chishima Real Estate](https://shizune.co/investors/profile/chishima-real-estate) — VC Fund, 2 deals together
- [HT Capital](https://shizune.co/investors/profile/ht-capital-5afe) — VC Fund, 2 deals together
- [Nanto Bank](https://shizune.co/investors/profile/nanto-bank) — VC Fund, 2 deals together
- [Ogaki Kyoritsu Bank](https://shizune.co/investors/profile/ogaki-kyoritsu-bank) — VC Fund, 2 deals together
- [Osaka University Venture Capital](https://shizune.co/investors/profile/osaka-university-venture-capital) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [Medical Investors in Japan](https://shizune.co/investors/medical-investors-japan)
- [Medical Device Investors in Japan](https://shizune.co/investors/medical-device-investors-japan)
- [Medical Device VC Funds in Japan](https://shizune.co/investors/medical-device-vc-funds-japan)

## FAQ

### What does Miraca Holdings invest in?

Miraca Holdings invests primarily in Medical, Biotechnology and Consulting startups, most often at Funding Round and Venture - Series Unknown stage. Most of the 7 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Miraca Holdings last invest?

The most recent investment recorded for Miraca Holdings closed in Jun 2020. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co